寻找 AML 中安全有效的 CAR-T 靶点
The search for safe and effective CAR-T targets in AML.
88.4分
★★★★★
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 29
条件筛选 · 已选 2 项 · 共 29 条展开收起
异基因移植后急性髓系白血病复发中重编程失败的移植物抗白血病免疫的研究进展
Progress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.
81.4分
★★★★☆
站内排序·非疗效
新型靶向治疗与细胞免疫治疗使复发/难治性急性髓系白血病患者能够接受异基因造血干细胞移植
Novel targeted therapy and cellular immunotherapy enabling allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid le
80.3分
★★★★☆
站内排序·非疗效
抗 CD123 CAR-T 治疗联合自体 SCT 及维奈克拉维持治疗用于不适合异基因移植的难治性 BPDCN：一例病例报告及文献复习
Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case
76.9分
★★★★☆
站内排序·非疗效
急性髓系白血病 CAR-T 细胞治疗的新兴策略：通过双抗原靶向克服异质性并提高安全性
Emerging strategies in CAR-T cell therapy for acute myeloid leukemia: overcoming heterogeneity and improving safety through dual-antigen targeting.
74.1分
★★★★☆
站内排序·非疗效
选 BE 还是选 PE：先导编辑器为基于表位编辑的免疫治疗提供更多选择
To BE or to PE: Prime editors provide more choices for epitope-editing-based immunotherapy.
65.1分
★★★☆☆
站内排序·非疗效
CD37 是治疗急性髓系白血病的安全嵌合抗原受体靶点
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia.
64.0分
★★★☆☆
站内排序·非疗效
表位工程化的人类造血干细胞可免受 CD123 靶向免疫疗法的攻击
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.
62.9分
★★★☆☆
站内排序·非疗效
表位编辑实现急性髓系白血病的靶向免疫治疗
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.
62.9分
★★★☆☆
站内排序·非疗效
急性髓系白血病中靶向 CD123 的同种异体 TCRαβ 缺陷 CAR-T 细胞
Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia.
62.5分
★★★☆☆
站内排序·非疗效